Tuesday, October 18, 2011

Johnson & Johnson, iScience sign supply deal

IScience Interventional said Tuesday it has signed a clinical and commercial supply agreement with Johnson & Johnson Pharmaceutical Research & Development LLC and its affiliates.
Menlo Park-based iScience specializes in therapies for anterior and posterior ocular diseases. It is expected to supply microcatheters to Johnson & Johnson for cell therapy clinical trials to treat retinal degeneration.

No comments:

Post a Comment